全体要約
ネットワーク型POCグルコース検査装置市場は、2022年の売上高を基に、2023年から2029年にかけての地域別および市場セクター別の予測を提供しています。市場は、アメリカ、ヨーロッパ、中国などの地域で成長が見込まれ、特に米国市場は2022年から2029年にかけての成長率が注目されています。主要企業には、ロシュホールディングAGやジョンソン・エンド・ジョンソンなどが含まれ、2022年には上位2社が市場の大部分を占めています。
このレポートは、ネットワーク型POCグルコース検査装置の製品タイプ、アプリケーション、主要メーカー、地域別の市場シェアと成長機会を詳述しています。市場は、病院、クリニック、家庭用などの用途に分かれ、各地域での成長機会が強調されています。市場の成長を促進する要因や、COVID-19やロシア・ウクライナ戦争の影響についても分析されています。
関連する質問
Roche Holding AG, Ascensia Diabetes Care Holdings AG, Nova Biomedical, LifeScan, Inc., Danaher Corporation, Prodigy Diabetes Care, Johnson & Johnson, Nipro, ACON Laboratories, Inc., Trividia Health, Inc., Panasonic Healthcare Holdings, EKF Diagnostics, Omron, B. Braun, 77 Elektronika, AgaMatrix, Terumo
製品セグメンテーションのトレンド, 地域別市場の成長機会, 主要企業の戦略と市場シェア
概要
このインサイトレポートは、世界のネットワークポイントオブケアグルコーステストデバイスの状況について包括的な分析を提供し、製品セグメンテーション、会社設立、収益、市場シェア、最新の開発、M&A活動に関連する主要なトレンドを強調しています。また、このレポートは、ネットワークポイントオブケアグルコーステストデバイスのポートフォリオと能力、市場参入戦略、市場ポジション、地理的展開に焦点を当て、主要なグローバル企業の戦略を分析し、加速する世界のネットワークポイントオブケアグルコーステストデバイス市場におけるこれらの企業のユニークな位置をよりよく理解するためのものです。
このインサイトレポートは、ネットワークポイントオブケアグルコーステストデバイスの世界的な見通しを形成する主要な市場動向、ドライバー、影響要因を評価し、タイプ、アプリケーション、地域、市場規模別に予測を分解し、新たな機会のポケットを浮き彫りにします。数百のボトムアップの質的および量的市場インプットに基づく透明な方法論を用いたこの研究の予測は、ネットワークポイントオブケアグルコーステストデバイスの現在の状態と将来の軌道に関する非常に詳細な見解を提供します。
グローバルネットワークポイントオブケアグルコーステストデバイス市場の規模は、2022年のXX米ドルから2029年のXX米ドルに成長すると予測されています。2023年から2029年までの間にCAGRで成長することが期待されています。
米国のネットワークポイントオブケアグルコーステストデバイス市場は、2022年のXX米ドルから2029年のXX米ドルに増加すると推定されており、2023年から2029年までの期間でCAGRはXX%です。
中国のネットワークポイントオブケアグルコーステストデバイスの市場は、2022年のXX米ドルから2029年にはXX米ドルに増加すると推定されており、2023年から2029年までの CAGR は % です。
ヨーロッパ市場は、ネットワークポイントオブケア血糖測定器が2022年のXX米ドルから2029年までにXX米ドルに増加すると推定されており、2023年から2029年までの間にXX%のCAGRで成長する見込みです。
グローバルな主要なネットワークポイント・オブ・ケア血糖測定装置のプレイヤーには、ロシュホールディングAG、アセンシア・ダイアビーティス・ケア・ホールディングスAG、ノババイオメディカル、ライフスキャン、ダナハーコーポレーション、プロディジー・ダイアビーティス・ケア、ジョンソン・エンド・ジョンソン、ニプロ、ACONラボラトリーズなどがあります。収益の面では、2022年に世界の2大企業がほぼXX%のシェアを占めました。
本報告書では、製品タイプ、アプリケーション、主要メーカー、主要地域および国別のネットワークポイントオブケアグルコーステストデバイス市場の包括的な概要、市場シェア、および成長機会を提示しています。
市場セグメンテーション
型によるセグメンテーション
0.5uL/0.6uL
1μL
1.5uL
その他
用途別セグメンテーション
病院
クリニック
家庭
この報告書では、地域別に市場を分割しています：
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
中東およびアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、プライマリーエキスパートから得られた情報と、企業のカバレッジ、製品ポートフォリオ、市場浸透率を分析に基づいて選定されています。
ロシュホールディングAG
アセンシア・ダイアベティス・ケア・ホールディングスAG
ノバ・バイオメディカル
ライフスキャン社
ダナハー・コーポレーション
プロディジー・ダイアベティス・ケア
ジョンソン・エンド・ジョンソン
ニプロ
アコンラボラトリーズ社
トリビディアヘルス株式会社
パナソニックヘルスケアホールディングス
EKF診断
オムロン
B. ブラウン
77 エレクトロニカ
アガマトリックス
テルモ
本レポートでの主要な質問
グローバルネットワークポイント・オブ・ケアグルコーステストデバイス市場の10年の見通しは何ですか？
ネットワーク・ポイント・オブ・ケア・グルコーステストデバイス市場の成長を促進している要因は、世界的および地域別に何ですか？
どの技術が市場と地域によって最も速い成長が見込まれていますか？
ネットワークポイントオブケアグルコーステストデバイスの市場機会は、エンドマーケットの規模によってどのように異なりますか？
ネットワーク・ポイントオブケア・グルコーステストデバイスは、タイプやアプリケーション別にどのように分類されますか？
COVID-19とロシア・ウクライナ戦争の影響は何ですか？
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルのネットワーク型POCグルコース検査装置、年間売上、2018年～2029年
2.1.2 ネットワーク型POCグルコース検査装置の世界市場の現状分析・将来予測、地理別、2018年、2022年および2029年
2.1.3 ネットワーク型POCグルコース検査装置の世界市場の現状分析・将来予測、国・地域別、2018年、2022年および2029年
2.2 ネットワーク型POCグルコース検査装置セグメント、タイプ別
2.2.1 0.5uL/0.6uL
2.2.2 1uL
2.2.3 1.5uL
2.2.4 その他
2.3 ネットワーク型POCグルコース検査装置の売上、タイプ別
2.3.1 グローバルにおけるネットワーク型POCグルコース検査装置の売上・市場シェア、タイプ別（2018年～2023年）
2.3.2 ネットワーク型POCグルコース検査装置のグローバルレベニュー・市場シェア、タイプ別（2018～2023年）
2.3.3 グローバルのネットワーク型POCグルコース検査装置、販売価格（タイプ別）（2018年～2023年）
2.4 ネットワーク型POCグルコース検査装置セグメント、用途別
2.4.1 病院
2.4.2 クリニック
2.4.3 家庭用
2.5 ネットワーク型POCグルコース検査装置の売上、用途別
2.5.1 グローバルのネットワーク型POCグルコース検査装置、収益・市場シェア（用途別）（2018年～2023年）
2.5.2 ネットワーク型POCグルコース検査装置のグローバルレベニュー・市場シェア、用途別（2018～2023年）
2.5.3 グローバルのネットワーク型POCグルコース検査装置、販売価格（用途別）（2018年～2023年）
3 グローバルにおけるネットワーク型POCグルコース検査装置、企業別
3.1 グローバルにおけるネットワーク型POCグルコース検査装置市場のブレークダウンデータ、企業別
3.1.1 グローバルにおけるネットワーク型POCグルコース検査装置の年間売上、企業別（2018年～2023年）
3.1.2 グローバルにおけるネットワーク型POCグルコース検査装置の売上・市場シェア、企業別（2018年～2023年）
3.2 グローバルにおけるネットワーク型POCグルコース検査装置の年間収益、企業別（2018年～2023年）
3.2.1 グローバルにおけるネットワーク型POCグルコース検査装置市場の収益規模、企業別（2018年～2023年）
3.2.2 グローバルにおけるネットワーク型POCグルコース検査装置市場の収益シェア、企業別（2018年～2023年）
3.3 グローバルにおけるネットワーク型POCグルコース検査装置の販売価格、企業別
3.4 ネットワーク型POCグルコース検査装置の主要メーカー、生産地域分布、販売地域、製品タイプ
3.4.1 ネットワーク型POCグルコース検査装置の主要メーカー、製品と拠点の分布
3.4.2 プレイヤーが提供しているネットワーク型POCグルコース検査装置製品
3.5 市場集中度分析
3.5.1 競合情勢分析
3.5.2 集中度レシオ（CR3、CR5、CR10）（2018年～2023年）
3.6 新製品・潜在的参入
3.7 M&A、拡大
4 ネットワーク型POCグルコース検査装置の世界市場過去推移レビュー、地理別
4.1 ネットワーク型POCグルコース検査装置の世界市場規模の過去推移、地理別（2018年～2023年）
4.1.1 グローバルにおけるネットワーク型POCグルコース検査装置の年間売上、地理別（2018年～2023年）
4.1.2 グローバルにおけるネットワーク型POCグルコース検査装置の年間収益、地理別（2018年～2023年）
4.2 ネットワーク型POCグルコース検査装置の世界市場規模の過去推移、国・地域別（2018年～2023年）
4.2.1 グローバルにおけるネットワーク型POCグルコース検査装置の年間売上、国・地域別（2018年～2023年）
4.2.2 グローバルにおけるネットワーク型POCグルコース検査装置の年間収益、国・地域別（2018年～2023年）
4.3 アメリカズにおけるネットワーク型POCグルコース検査装置の売上成長
4.4 APACにおけるネットワーク型POCグルコース検査装置の売上成長
4.5 ヨーロッパにおけるネットワーク型POCグルコース検査装置の売上成長
4.6 中東・アフリカにおけるネットワーク型POCグルコース検査装置の売上成長
5 アメリカズ
5.1 アメリカズにおけるネットワーク型POCグルコース検査装置の売上、国別
5.1.1 アメリカズにおけるネットワーク型POCグルコース検査装置の売上規模、国別（2018年～2023年）
5.1.2 アメリカズにおけるネットワーク型POCグルコース検査装置市場の収益規模、国別（2018年～2023年）
5.2 アメリカズにおけるネットワーク型POCグルコース検査装置の売上、タイプ別
5.3 アメリカズにおけるネットワーク型POCグルコース検査装置の売上、用途別
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおけるネットワーク型POCグルコース検査装置の売上、地域別
6.1.1 APACにおけるネットワーク型POCグルコース検査装置の売上規模、地域別（2018年～2023年）
6.1.2 APACにおけるネットワーク型POCグルコース検査装置市場の収益規模、地域別（2018年～2023年）
6.2 APACにおけるネットワーク型POCグルコース検査装置の売上、タイプ別
6.3 APACにおけるネットワーク型POCグルコース検査装置の売上、用途別
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
6.10 中国の台湾
7 ヨーロッパ
7.1 ヨーロッパにおけるネットワーク型POCグルコース検査装置、国別
7.1.1 ヨーロッパにおけるネットワーク型POCグルコース検査装置の売上規模、国別（2018年～2023年）
7.1.2 ヨーロッパにおけるネットワーク型POCグルコース検査装置市場の収益規模、国別（2018年～2023年）
7.2 ヨーロッパにおけるネットワーク型POCグルコース検査装置の売上、タイプ別
7.3 ヨーロッパにおけるネットワーク型POCグルコース検査装置の売上、用途別
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカにおけるネットワーク型POCグルコース検査装置、国別
8.1.1 中東・アフリカにおけるネットワーク型POCグルコース検査装置の売上規模、国別（2018年～2023年）
8.1.2 中東・アフリカにおけるネットワーク型POCグルコース検査装置市場の収益規模、国別（2018年～2023年）
8.2 中東・アフリカにおけるネットワーク型POCグルコース検査装置の売上、タイプ別
8.3 中東・アフリカにおけるネットワーク型POCグルコース検査装置の売上、用途別
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 製造コスト構造分析
10.1 原料・サプライヤー
10.2 ネットワーク型POCグルコース検査装置の製造コスト構造分析
10.3 ネットワーク型POCグルコース検査装置の製造プロセス分析
10.4 ネットワーク型POCグルコース検査装置のインダストリーチェーン構造
11 マーケティング・流通・顧客
11.1 販売チャネル
11.1.1 直接チャネル
11.1.2 間接チャネル
11.2 ネットワーク型POCグルコース検査装置の流通業者
11.3 ネットワーク型POCグルコース検査装置の顧客
12 ネットワーク型POCグルコース検査装置の世界市場予測レビュー、地理別
12.1 グローバルにおけるネットワーク型POCグルコース検査装置の市場規模予測、地域別
12.1.1 グローバルのネットワーク型POCグルコース検査装置、市場予測（地域別）（2024年～2029年）
12.1.2 グローバルのネットワーク型POCグルコース検査装置、年間収益予測（地域別）（2024年～2029年）
12.2 アメリカズにおける予測、国別
12.3 APACにおける予測、地域別
12.4 ヨーロッパにおける予測、国別
12.5 中東・アフリカにおける予測、国別
12.6 グローバルにおけるネットワーク型POCグルコース検査装置の市場予測、タイプ別
12.7 グローバルにおけるネットワーク型POCグルコース検査装置の市場予測、用途別
13 キープレイヤー分析
13.1 Roche Holding AG
13.1.1 Roche Holding AG：企業情報
13.1.2 Roche Holding AG：ネットワーク型POCグルコース検査装置製品ポートフォリオと特徴
13.1.3 Roche Holding AG：ネットワーク型POCグルコース検査装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.1.4 Roche Holding AG：主要事業概要
13.1.5 Roche Holding AG：直近の展開
13.2 Ascensia Diabetes Care Holdings AG
13.2.1 Ascensia Diabetes Care Holdings AG：企業情報
13.2.2 Ascensia Diabetes Care Holdings AG：ネットワーク型POCグルコース検査装置製品ポートフォリオと特徴
13.2.3 Ascensia Diabetes Care Holdings AG：ネットワーク型POCグルコース検査装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.2.4 Ascensia Diabetes Care Holdings AG：主要事業概要
13.2.5 Ascensia Diabetes Care Holdings AG：直近の展開
13.3 Nova Biomedical
13.3.1 Nova Biomedical：企業情報
13.3.2 Nova Biomedical：ネットワーク型POCグルコース検査装置製品ポートフォリオと特徴
13.3.3 Nova Biomedical：ネットワーク型POCグルコース検査装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.3.4 Nova Biomedical：主要事業概要
13.3.5 Nova Biomedical：直近の展開
13.4 LifeScan, Inc
13.5 Danaher Corporation
13.5.1 Danaher Corporation：企業情報
13.5.2 Danaher Corporation：ネットワーク型POCグルコース検査装置製品ポートフォリオと特徴
13.5.3 Danaher Corporation：ネットワーク型POCグルコース検査装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.5.4 Danaher Corporation：主要事業概要
13.5.5 Danaher Corporation：直近の展開
13.6 Prodigy Diabetes Care
13.6.1 Prodigy Diabetes Care：企業情報
13.6.2 Prodigy Diabetes Care：ネットワーク型POCグルコース検査装置製品ポートフォリオと特徴
13.6.3 Prodigy Diabetes Care：ネットワーク型POCグルコース検査装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.6.4 Prodigy Diabetes Care：主要事業概要
13.6.5 Prodigy Diabetes Care：直近の展開
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson：企業情報
13.7.2 Johnson & Johnson：ネットワーク型POCグルコース検査装置製品ポートフォリオと特徴
13.7.3 Johnson & Johnson：ネットワーク型POCグルコース検査装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.7.4 Johnson & Johnson：主要事業概要
13.7.5 Johnson & Johnson：直近の展開
13.8 Nipro
13.8.1 Nipro：企業情報
13.8.2 Nipro：ネットワーク型POCグルコース検査装置製品ポートフォリオと特徴
13.8.3 Nipro：ネットワーク型POCグルコース検査装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.8.4 Nipro：主要事業概要
13.8.5 Nipro：直近の展開
13.9 ACON Laboratories, Inc
13.10 Trividia Health, Inc
13.11 Panasonic Healthcare Holdings
13.11.1 Panasonic Healthcare Holdings：企業情報
13.11.2 Panasonic Healthcare Holdings：ネットワーク型POCグルコース検査装置製品ポートフォリオと特徴
13.11.3 Panasonic Healthcare Holdings：ネットワーク型POCグルコース検査装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.11.4 Panasonic Healthcare Holdings：主要事業概要
13.11.5 Panasonic Healthcare Holdings：直近の展開
13.12 EKF Diagnostics
13.12.1 EKF Diagnostics：企業情報
13.12.2 EKF Diagnostics：ネットワーク型POCグルコース検査装置製品ポートフォリオと特徴
13.12.3 EKF Diagnostics：ネットワーク型POCグルコース検査装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.12.4 EKF Diagnostics：主要事業概要
13.12.5 EKF Diagnostics：直近の展開
13.13 Omron
13.13.1 Omron：企業情報
13.13.2 Omron：ネットワーク型POCグルコース検査装置製品ポートフォリオと特徴
13.13.3 Omron：ネットワーク型POCグルコース検査装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.13.4 Omron：主要事業概要
13.13.5 Omron：直近の展開
13.14 B\. Braun
13.14.1 B\. Braun：企業情報
13.14.2 B\. Braun：ネットワーク型POCグルコース検査装置製品ポートフォリオと特徴
13.14.3 B\. Braun：ネットワーク型POCグルコース検査装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.14.4 B\. Braun：主要事業概要
13.14.5 B\. Braun：直近の展開
13.15 77 Elektronika
13.15.1 77 Elektronika：企業情報
13.15.2 77 Elektronika：ネットワーク型POCグルコース検査装置製品ポートフォリオと特徴
13.15.3 77 Elektronika：ネットワーク型POCグルコース検査装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.15.4 77 Elektronika：主要事業概要
13.15.5 77 Elektronika：直近の展開
13.16 AgaMatrix
13.16.1 AgaMatrix：企業情報
13.16.2 AgaMatrix：ネットワーク型POCグルコース検査装置製品ポートフォリオと特徴
13.16.3 AgaMatrix：ネットワーク型POCグルコース検査装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.16.4 AgaMatrix：主要事業概要
13.16.5 AgaMatrix：直近の展開
13.17 Terumo
13.17.1 Terumo：企業情報
13.17.2 Terumo：ネットワーク型POCグルコース検査装置製品ポートフォリオと特徴
13.17.3 Terumo：ネットワーク型POCグルコース検査装置売上・収益・価格およびグロスマージン（2018年～2023年）
13.17.4 Terumo：主要事業概要
13.17.5 Terumo：直近の展開
14 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
This Insight Report provides a comprehensive analysis of the global Network Point-of-Care Glucose Testing Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Network Point-of-Care Glucose Testing Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Network Point-of-Care Glucose Testing Device market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Network Point-of-Care Glucose Testing Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Network Point-of-Care Glucose Testing Device.
The global Network Point-of-Care Glucose Testing Device market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Network Point-of-Care Glucose Testing Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Network Point-of-Care Glucose Testing Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Network Point-of-Care Glucose Testing Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Network Point-of-Care Glucose Testing Device players cover Roche Holding AG, Ascensia Diabetes Care Holdings AG, Nova Biomedical, LifeScan, Inc., Danaher Corporation, Prodigy Diabetes Care, Johnson & Johnson, Nipro and ACON Laboratories, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Network Point-of-Care Glucose Testing Device market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
0.5uL/0.6uL
1uL
1.5uL
Others
Segmentation by application
Hospital
Clinic
Household
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche Holding AG
Ascensia Diabetes Care Holdings AG
Nova Biomedical
LifeScan, Inc.
Danaher Corporation
Prodigy Diabetes Care
Johnson & Johnson
Nipro
ACON Laboratories, Inc.
Trividia Health, Inc.
Panasonic Healthcare Holdings
EKF Diagnostics
Omron
B. Braun
77 Elektronika
AgaMatrix
Terumo
Key Questions Addressed in this Report
What is the 10-year outlook for the global Network Point-of-Care Glucose Testing Device market?
What factors are driving Network Point-of-Care Glucose Testing Device market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Network Point-of-Care Glucose Testing Device market opportunities vary by end market size?
How does Network Point-of-Care Glucose Testing Device break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Network Point-of-Care Glucose Testing Device Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Network Point-of-Care Glucose Testing Device by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Network Point-of-Care Glucose Testing Device by Country/Region, 2018, 2022 & 2029
2.2 Network Point-of-Care Glucose Testing Device Segment by Type
2.2.1 0.5uL/0.6uL
2.2.2 1uL
2.2.3 1.5uL
2.2.4 Others
2.3 Network Point-of-Care Glucose Testing Device Sales by Type
2.3.1 Global Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2018-2023)
2.3.2 Global Network Point-of-Care Glucose Testing Device Revenue and Market Share by Type (2018-2023)
2.3.3 Global Network Point-of-Care Glucose Testing Device Sale Price by Type (2018-2023)
2.4 Network Point-of-Care Glucose Testing Device Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Household
2.5 Network Point-of-Care Glucose Testing Device Sales by Application
2.5.1 Global Network Point-of-Care Glucose Testing Device Sale Market Share by Application (2018-2023)
2.5.2 Global Network Point-of-Care Glucose Testing Device Revenue and Market Share by Application (2018-2023)
2.5.3 Global Network Point-of-Care Glucose Testing Device Sale Price by Application (2018-2023)
3 Global Network Point-of-Care Glucose Testing Device by Company
3.1 Global Network Point-of-Care Glucose Testing Device Breakdown Data by Company
3.1.1 Global Network Point-of-Care Glucose Testing Device Annual Sales by Company (2018-2023)
3.1.2 Global Network Point-of-Care Glucose Testing Device Sales Market Share by Company (2018-2023)
3.2 Global Network Point-of-Care Glucose Testing Device Annual Revenue by Company (2018-2023)
3.2.1 Global Network Point-of-Care Glucose Testing Device Revenue by Company (2018-2023)
3.2.2 Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Company (2018-2023)
3.3 Global Network Point-of-Care Glucose Testing Device Sale Price by Company
3.4 Key Manufacturers Network Point-of-Care Glucose Testing Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Network Point-of-Care Glucose Testing Device Product Location Distribution
3.4.2 Players Network Point-of-Care Glucose Testing Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Network Point-of-Care Glucose Testing Device by Geographic Region
4.1 World Historic Network Point-of-Care Glucose Testing Device Market Size by Geographic Region (2018-2023)
4.1.1 Global Network Point-of-Care Glucose Testing Device Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Network Point-of-Care Glucose Testing Device Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Network Point-of-Care Glucose Testing Device Market Size by Country/Region (2018-2023)
4.2.1 Global Network Point-of-Care Glucose Testing Device Annual Sales by Country/Region (2018-2023)
4.2.2 Global Network Point-of-Care Glucose Testing Device Annual Revenue by Country/Region (2018-2023)
4.3 Americas Network Point-of-Care Glucose Testing Device Sales Growth
4.4 APAC Network Point-of-Care Glucose Testing Device Sales Growth
4.5 Europe Network Point-of-Care Glucose Testing Device Sales Growth
4.6 Middle East & Africa Network Point-of-Care Glucose Testing Device Sales Growth
5 Americas
5.1 Americas Network Point-of-Care Glucose Testing Device Sales by Country
5.1.1 Americas Network Point-of-Care Glucose Testing Device Sales by Country (2018-2023)
5.1.2 Americas Network Point-of-Care Glucose Testing Device Revenue by Country (2018-2023)
5.2 Americas Network Point-of-Care Glucose Testing Device Sales by Type
5.3 Americas Network Point-of-Care Glucose Testing Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Network Point-of-Care Glucose Testing Device Sales by Region
6.1.1 APAC Network Point-of-Care Glucose Testing Device Sales by Region (2018-2023)
6.1.2 APAC Network Point-of-Care Glucose Testing Device Revenue by Region (2018-2023)
6.2 APAC Network Point-of-Care Glucose Testing Device Sales by Type
6.3 APAC Network Point-of-Care Glucose Testing Device Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Network Point-of-Care Glucose Testing Device by Country
7.1.1 Europe Network Point-of-Care Glucose Testing Device Sales by Country (2018-2023)
7.1.2 Europe Network Point-of-Care Glucose Testing Device Revenue by Country (2018-2023)
7.2 Europe Network Point-of-Care Glucose Testing Device Sales by Type
7.3 Europe Network Point-of-Care Glucose Testing Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Network Point-of-Care Glucose Testing Device by Country
8.1.1 Middle East & Africa Network Point-of-Care Glucose Testing Device Sales by Country (2018-2023)
8.1.2 Middle East & Africa Network Point-of-Care Glucose Testing Device Revenue by Country (2018-2023)
8.2 Middle East & Africa Network Point-of-Care Glucose Testing Device Sales by Type
8.3 Middle East & Africa Network Point-of-Care Glucose Testing Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Network Point-of-Care Glucose Testing Device
10.3 Manufacturing Process Analysis of Network Point-of-Care Glucose Testing Device
10.4 Industry Chain Structure of Network Point-of-Care Glucose Testing Device
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Network Point-of-Care Glucose Testing Device Distributors
11.3 Network Point-of-Care Glucose Testing Device Customer
12 World Forecast Review for Network Point-of-Care Glucose Testing Device by Geographic Region
12.1 Global Network Point-of-Care Glucose Testing Device Market Size Forecast by Region
12.1.1 Global Network Point-of-Care Glucose Testing Device Forecast by Region (2024-2029)
12.1.2 Global Network Point-of-Care Glucose Testing Device Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Network Point-of-Care Glucose Testing Device Forecast by Type
12.7 Global Network Point-of-Care Glucose Testing Device Forecast by Application
13 Key Players Analysis
13.1 Roche Holding AG
13.1.1 Roche Holding AG Company Information
13.1.2 Roche Holding AG Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.1.3 Roche Holding AG Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Holding AG Main Business Overview
13.1.5 Roche Holding AG Latest Developments
13.2 Ascensia Diabetes Care Holdings AG
13.2.1 Ascensia Diabetes Care Holdings AG Company Information
13.2.2 Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.2.3 Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Ascensia Diabetes Care Holdings AG Main Business Overview
13.2.5 Ascensia Diabetes Care Holdings AG Latest Developments
13.3 Nova Biomedical
13.3.1 Nova Biomedical Company Information
13.3.2 Nova Biomedical Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.3.3 Nova Biomedical Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Nova Biomedical Main Business Overview
13.3.5 Nova Biomedical Latest Developments
13.4 LifeScan, Inc.
13.4.1 LifeScan, Inc. Company Information
13.4.2 LifeScan, Inc. Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.4.3 LifeScan, Inc. Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 LifeScan, Inc. Main Business Overview
13.4.5 LifeScan, Inc. Latest Developments
13.5 Danaher Corporation
13.5.1 Danaher Corporation Company Information
13.5.2 Danaher Corporation Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.5.3 Danaher Corporation Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Danaher Corporation Main Business Overview
13.5.5 Danaher Corporation Latest Developments
13.6 Prodigy Diabetes Care
13.6.1 Prodigy Diabetes Care Company Information
13.6.2 Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.6.3 Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Prodigy Diabetes Care Main Business Overview
13.6.5 Prodigy Diabetes Care Latest Developments
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Information
13.7.2 Johnson & Johnson Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.7.3 Johnson & Johnson Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Johnson & Johnson Main Business Overview
13.7.5 Johnson & Johnson Latest Developments
13.8 Nipro
13.8.1 Nipro Company Information
13.8.2 Nipro Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.8.3 Nipro Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Nipro Main Business Overview
13.8.5 Nipro Latest Developments
13.9 ACON Laboratories, Inc.
13.9.1 ACON Laboratories, Inc. Company Information
13.9.2 ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.9.3 ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 ACON Laboratories, Inc. Main Business Overview
13.9.5 ACON Laboratories, Inc. Latest Developments
13.10 Trividia Health, Inc.
13.10.1 Trividia Health, Inc. Company Information
13.10.2 Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.10.3 Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Trividia Health, Inc. Main Business Overview
13.10.5 Trividia Health, Inc. Latest Developments
13.11 Panasonic Healthcare Holdings
13.11.1 Panasonic Healthcare Holdings Company Information
13.11.2 Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.11.3 Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Panasonic Healthcare Holdings Main Business Overview
13.11.5 Panasonic Healthcare Holdings Latest Developments
13.12 EKF Diagnostics
13.12.1 EKF Diagnostics Company Information
13.12.2 EKF Diagnostics Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.12.3 EKF Diagnostics Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 EKF Diagnostics Main Business Overview
13.12.5 EKF Diagnostics Latest Developments
13.13 Omron
13.13.1 Omron Company Information
13.13.2 Omron Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.13.3 Omron Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Omron Main Business Overview
13.13.5 Omron Latest Developments
13.14 B. Braun
13.14.1 B. Braun Company Information
13.14.2 B. Braun Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.14.3 B. Braun Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 B. Braun Main Business Overview
13.14.5 B. Braun Latest Developments
13.15 77 Elektronika
13.15.1 77 Elektronika Company Information
13.15.2 77 Elektronika Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.15.3 77 Elektronika Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 77 Elektronika Main Business Overview
13.15.5 77 Elektronika Latest Developments
13.16 AgaMatrix
13.16.1 AgaMatrix Company Information
13.16.2 AgaMatrix Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.16.3 AgaMatrix Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 AgaMatrix Main Business Overview
13.16.5 AgaMatrix Latest Developments
13.17 Terumo
13.17.1 Terumo Company Information
13.17.2 Terumo Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications
13.17.3 Terumo Network Point-of-Care Glucose Testing Device Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Terumo Main Business Overview
13.17.5 Terumo Latest Developments
14 Research Findings and Conclusion
List of Tables Table 1. Network Point-of-Care Glucose Testing Device Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Network Point-of-Care Glucose Testing Device Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of 0.5uL/0.6uL Table 4. Major Players of 1uL Table 5. Major Players of 1.5uL Table 6. Major Players of Others Table 7. Global Network Point-of-Care Glucose Testing Device Sales by Type (2018-2023) & (K Units) Table 8. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2018-2023) Table 9. Global Network Point-of-Care Glucose Testing Device Revenue by Type (2018-2023) & ($ million) Table 10. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Type (2018-2023) Table 11. Global Network Point-of-Care Glucose Testing Device Sale Price by Type (2018-2023) & (US$/Unit) Table 12. Global Network Point-of-Care Glucose Testing Device Sales by Application (2018-2023) & (K Units) Table 13. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2018-2023) Table 14. Global Network Point-of-Care Glucose Testing Device Revenue by Application (2018-2023) Table 15. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Application (2018-2023) Table 16. Global Network Point-of-Care Glucose Testing Device Sale Price by Application (2018-2023) & (US$/Unit) Table 17. Global Network Point-of-Care Glucose Testing Device Sales by Company (2018-2023) & (K Units) Table 18. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Company (2018-2023) Table 19. Global Network Point-of-Care Glucose Testing Device Revenue by Company (2018-2023) ($ Millions) Table 20. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Company (2018-2023) Table 21. Global Network Point-of-Care Glucose Testing Device Sale Price by Company (2018-2023) & (US$/Unit) Table 22. Key Manufacturers Network Point-of-Care Glucose Testing Device Producing Area Distribution and Sales Area Table 23. Players Network Point-of-Care Glucose Testing Device Products Offered Table 24. Network Point-of-Care Glucose Testing Device Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 25. New Products and Potential Entrants Table 26. Mergers & Acquisitions, Expansion Table 27. Global Network Point-of-Care Glucose Testing Device Sales by Geographic Region (2018-2023) & (K Units) Table 28. Global Network Point-of-Care Glucose Testing Device Sales Market Share Geographic Region (2018-2023) Table 29. Global Network Point-of-Care Glucose Testing Device Revenue by Geographic Region (2018-2023) & ($ millions) Table 30. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Geographic Region (2018-2023) Table 31. Global Network Point-of-Care Glucose Testing Device Sales by Country/Region (2018-2023) & (K Units) Table 32. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Country/Region (2018-2023) Table 33. Global Network Point-of-Care Glucose Testing Device Revenue by Country/Region (2018-2023) & ($ millions) Table 34. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Country/Region (2018-2023) Table 35. Americas Network Point-of-Care Glucose Testing Device Sales by Country (2018-2023) & (K Units) Table 36. Americas Network Point-of-Care Glucose Testing Device Sales Market Share by Country (2018-2023) Table 37. Americas Network Point-of-Care Glucose Testing Device Revenue by Country (2018-2023) & ($ Millions) Table 38. Americas Network Point-of-Care Glucose Testing Device Revenue Market Share by Country (2018-2023) Table 39. Americas Network Point-of-Care Glucose Testing Device Sales by Type (2018-2023) & (K Units) Table 40. Americas Network Point-of-Care Glucose Testing Device Sales by Application (2018-2023) & (K Units) Table 41. APAC Network Point-of-Care Glucose Testing Device Sales by Region (2018-2023) & (K Units) Table 42. APAC Network Point-of-Care Glucose Testing Device Sales Market Share by Region (2018-2023) Table 43. APAC Network Point-of-Care Glucose Testing Device Revenue by Region (2018-2023) & ($ Millions) Table 44. APAC Network Point-of-Care Glucose Testing Device Revenue Market Share by Region (2018-2023) Table 45. APAC Network Point-of-Care Glucose Testing Device Sales by Type (2018-2023) & (K Units) Table 46. APAC Network Point-of-Care Glucose Testing Device Sales by Application (2018-2023) & (K Units) Table 47. Europe Network Point-of-Care Glucose Testing Device Sales by Country (2018-2023) & (K Units) Table 48. Europe Network Point-of-Care Glucose Testing Device Sales Market Share by Country (2018-2023) Table 49. Europe Network Point-of-Care Glucose Testing Device Revenue by Country (2018-2023) & ($ Millions) Table 50. Europe Network Point-of-Care Glucose Testing Device Revenue Market Share by Country (2018-2023) Table 51. Europe Network Point-of-Care Glucose Testing Device Sales by Type (2018-2023) & (K Units) Table 52. Europe Network Point-of-Care Glucose Testing Device Sales by Application (2018-2023) & (K Units) Table 53. Middle East & Africa Network Point-of-Care Glucose Testing Device Sales by Country (2018-2023) & (K Units) Table 54. Middle East & Africa Network Point-of-Care Glucose Testing Device Sales Market Share by Country (2018-2023) Table 55. Middle East & Africa Network Point-of-Care Glucose Testing Device Revenue by Country (2018-2023) & ($ Millions) Table 56. Middle East & Africa Network Point-of-Care Glucose Testing Device Revenue Market Share by Country (2018-2023) Table 57. Middle East & Africa Network Point-of-Care Glucose Testing Device Sales by Type (2018-2023) & (K Units) Table 58. Middle East & Africa Network Point-of-Care Glucose Testing Device Sales by Application (2018-2023) & (K Units) Table 59. Key Market Drivers & Growth Opportunities of Network Point-of-Care Glucose Testing Device Table 60. Key Market Challenges & Risks of Network Point-of-Care Glucose Testing Device Table 61. Key Industry Trends of Network Point-of-Care Glucose Testing Device Table 62. Network Point-of-Care Glucose Testing Device Raw Material Table 63. Key Suppliers of Raw Materials Table 64. Network Point-of-Care Glucose Testing Device Distributors List Table 65. Network Point-of-Care Glucose Testing Device Customer List Table 66. Global Network Point-of-Care Glucose Testing Device Sales Forecast by Region (2024-2029) & (K Units) Table 67. Global Network Point-of-Care Glucose Testing Device Revenue Forecast by Region (2024-2029) & ($ millions) Table 68. Americas Network Point-of-Care Glucose Testing Device Sales Forecast by Country (2024-2029) & (K Units) Table 69. Americas Network Point-of-Care Glucose Testing Device Revenue Forecast by Country (2024-2029) & ($ millions) Table 70. APAC Network Point-of-Care Glucose Testing Device Sales Forecast by Region (2024-2029) & (K Units) Table 71. APAC Network Point-of-Care Glucose Testing Device Revenue Forecast by Region (2024-2029) & ($ millions) Table 72. Europe Network Point-of-Care Glucose Testing Device Sales Forecast by Country (2024-2029) & (K Units) Table 73. Europe Network Point-of-Care Glucose Testing Device Revenue Forecast by Country (2024-2029) & ($ millions) Table 74. Middle East & Africa Network Point-of-Care Glucose Testing Device Sales Forecast by Country (2024-2029) & (K Units) Table 75. Middle East & Africa Network Point-of-Care Glucose Testing Device Revenue Forecast by Country (2024-2029) & ($ millions) Table 76. Global Network Point-of-Care Glucose Testing Device Sales Forecast by Type (2024-2029) & (K Units) Table 77. Global Network Point-of-Care Glucose Testing Device Revenue Forecast by Type (2024-2029) & ($ Millions) Table 78. Global Network Point-of-Care Glucose Testing Device Sales Forecast by Application (2024-2029) & (K Units) Table 79. Global Network Point-of-Care Glucose Testing Device Revenue Forecast by Application (2024-2029) & ($ Millions) Table 80. Roche Holding AG Basic Information, Network Point-of-Care Glucose Testing Device Manufacturing Base, Sales Area and Its Competitors Table 81. Roche Holding AG Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications Table 82. Roche Holding AG Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 83. Roche Holding AG Main Business Table 84. Roche Holding AG Latest Developments Table 85. Ascensia Diabetes Care Holdings AG Basic Information, Network Point-of-Care Glucose Testing Device Manufacturing Base, Sales Area and Its Competitors Table 86. Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications Table 87. Ascensia Diabetes Care Holdings AG Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 88. Ascensia Diabetes Care Holdings AG Main Business Table 89. Ascensia Diabetes Care Holdings AG Latest Developments Table 90. Nova Biomedical Basic Information, Network Point-of-Care Glucose Testing Device Manufacturing Base, Sales Area and Its Competitors Table 91. Nova Biomedical Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications Table 92. Nova Biomedical Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 93. Nova Biomedical Main Business Table 94. Nova Biomedical Latest Developments Table 95. LifeScan, Inc. Basic Information, Network Point-of-Care Glucose Testing Device Manufacturing Base, Sales Area and Its Competitors Table 96. LifeScan, Inc. Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications Table 97. LifeScan, Inc. Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 98. LifeScan, Inc. Main Business Table 99. LifeScan, Inc. Latest Developments Table 100. Danaher Corporation Basic Information, Network Point-of-Care Glucose Testing Device Manufacturing Base, Sales Area and Its Competitors Table 101. Danaher Corporation Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications Table 102. Danaher Corporation Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 103. Danaher Corporation Main Business Table 104. Danaher Corporation Latest Developments Table 105. Prodigy Diabetes Care Basic Information, Network Point-of-Care Glucose Testing Device Manufacturing Base, Sales Area and Its Competitors Table 106. Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications Table 107. Prodigy Diabetes Care Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 108. Prodigy Diabetes Care Main Business Table 109. Prodigy Diabetes Care Latest Developments Table 110. Johnson & Johnson Basic Information, Network Point-of-Care Glucose Testing Device Manufacturing Base, Sales Area and Its Competitors Table 111. Johnson & Johnson Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications Table 112. Johnson & Johnson Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 113. Johnson & Johnson Main Business Table 114. Johnson & Johnson Latest Developments Table 115. Nipro Basic Information, Network Point-of-Care Glucose Testing Device Manufacturing Base, Sales Area and Its Competitors Table 116. Nipro Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications Table 117. Nipro Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 118. Nipro Main Business Table 119. Nipro Latest Developments Table 120. ACON Laboratories, Inc. Basic Information, Network Point-of-Care Glucose Testing Device Manufacturing Base, Sales Area and Its Competitors Table 121. ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications Table 122. ACON Laboratories, Inc. Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 123. ACON Laboratories, Inc. Main Business Table 124. ACON Laboratories, Inc. Latest Developments Table 125. Trividia Health, Inc. Basic Information, Network Point-of-Care Glucose Testing Device Manufacturing Base, Sales Area and Its Competitors Table 126. Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications Table 127. Trividia Health, Inc. Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 128. Trividia Health, Inc. Main Business Table 129. Trividia Health, Inc. Latest Developments Table 130. Panasonic Healthcare Holdings Basic Information, Network Point-of-Care Glucose Testing Device Manufacturing Base, Sales Area and Its Competitors Table 131. Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications Table 132. Panasonic Healthcare Holdings Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 133. Panasonic Healthcare Holdings Main Business Table 134. Panasonic Healthcare Holdings Latest Developments Table 135. EKF Diagnostics Basic Information, Network Point-of-Care Glucose Testing Device Manufacturing Base, Sales Area and Its Competitors Table 136. EKF Diagnostics Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications Table 137. EKF Diagnostics Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 138. EKF Diagnostics Main Business Table 139. EKF Diagnostics Latest Developments Table 140. Omron Basic Information, Network Point-of-Care Glucose Testing Device Manufacturing Base, Sales Area and Its Competitors Table 141. Omron Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications Table 142. Omron Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 143. Omron Main Business Table 144. Omron Latest Developments Table 145. B. Braun Basic Information, Network Point-of-Care Glucose Testing Device Manufacturing Base, Sales Area and Its Competitors Table 146. B. Braun Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications Table 147. B. Braun Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 148. B. Braun Main Business Table 149. B. Braun Latest Developments Table 150. 77 Elektronika Basic Information, Network Point-of-Care Glucose Testing Device Manufacturing Base, Sales Area and Its Competitors Table 151. 77 Elektronika Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications Table 152. 77 Elektronika Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 153. 77 Elektronika Main Business Table 154. 77 Elektronika Latest Developments Table 155. AgaMatrix Basic Information, Network Point-of-Care Glucose Testing Device Manufacturing Base, Sales Area and Its Competitors Table 156. AgaMatrix Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications Table 157. AgaMatrix Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 158. AgaMatrix Main Business Table 159. AgaMatrix Latest Developments Table 160. Terumo Basic Information, Network Point-of-Care Glucose Testing Device Manufacturing Base, Sales Area and Its Competitors Table 161. Terumo Network Point-of-Care Glucose Testing Device Product Portfolios and Specifications Table 162. Terumo Network Point-of-Care Glucose Testing Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023) Table 163. Terumo Main Business Table 164. Terumo Latest Developments List of Figures Figure 1. Picture of Network Point-of-Care Glucose Testing Device Figure 2. Network Point-of-Care Glucose Testing Device Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Network Point-of-Care Glucose Testing Device Sales Growth Rate 2018-2029 (K Units) Figure 7. Global Network Point-of-Care Glucose Testing Device Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Network Point-of-Care Glucose Testing Device Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of 0.5uL/0.6uL Figure 10. Product Picture of 1uL Figure 11. Product Picture of 1.5uL Figure 12. Product Picture of Others Figure 13. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Type in 2022 Figure 14. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Type (2018-2023) Figure 15. Network Point-of-Care Glucose Testing Device Consumed in Hospital Figure 16. Global Network Point-of-Care Glucose Testing Device Market: Hospital (2018-2023) & (K Units) Figure 17. Network Point-of-Care Glucose Testing Device Consumed in Clinic Figure 18. Global Network Point-of-Care Glucose Testing Device Market: Clinic (2018-2023) & (K Units) Figure 19. Network Point-of-Care Glucose Testing Device Consumed in Household Figure 20. Global Network Point-of-Care Glucose Testing Device Market: Household (2018-2023) & (K Units) Figure 21. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2022) Figure 22. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Application in 2022 Figure 23. Network Point-of-Care Glucose Testing Device Sales Market by Company in 2022 (K Units) Figure 24. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Company in 2022 Figure 25. Network Point-of-Care Glucose Testing Device Revenue Market by Company in 2022 ($ Million) Figure 26. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Company in 2022 Figure 27. Global Network Point-of-Care Glucose Testing Device Sales Market Share by Geographic Region (2018-2023) Figure 28. Global Network Point-of-Care Glucose Testing Device Revenue Market Share by Geographic Region in 2022 Figure 29. Americas Network Point-of-Care Glucose Testing Device Sales 2018-2023 (K Units) Figure 30. Americas Network Point-of-Care Glucose Testing Device Revenue 2018-2023 ($ Millions) Figure 31. APAC Network Point-of-Care Glucose Testing Device Sales 2018-2023 (K Units) Figure 32. APAC Network Point-of-Care Glucose Testing Device Revenue 2018-2023 ($ Millions) Figure 33. Europe Network Point-of-Care Glucose Testing Device Sales 2018-2023 (K Units) Figure 34. Europe Network Point-of-Care Glucose Testing Device Revenue 2018-2023 ($ Millions) Figure 35. Middle East & Africa Network Point-of-Care Glucose Testing Device Sales 2018-2023 (K Units) Figure 36. Middle East & Africa Network Point-of-Care Glucose Testing Device Revenue 2018-2023 ($ Millions) Figure 37. Americas Network Point-of-Care Glucose Testing Device Sales Market Share by Country in 2022 Figure 38. Americas Network Point-of-Care Glucose Testing Device Revenue Market Share by Country in 2022 Figure 39. Americas Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2018-2023) Figure 40. Americas Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2018-2023) Figure 41. United States Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 42. Canada Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 43. Mexico Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 44. Brazil Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 45. APAC Network Point-of-Care Glucose Testing Device Sales Market Share by Region in 2022 Figure 46. APAC Network Point-of-Care Glucose Testing Device Revenue Market Share by Regions in 2022 Figure 47. APAC Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2018-2023) Figure 48. APAC Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2018-2023) Figure 49. China Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 50. Japan Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 51. South Korea Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 52. Southeast Asia Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 53. India Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 54. Australia Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 55. China Taiwan Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 56. Europe Network Point-of-Care Glucose Testing Device Sales Market Share by Country in 2022 Figure 57. Europe Network Point-of-Care Glucose Testing Device Revenue Market Share by Country in 2022 Figure 58. Europe Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2018-2023) Figure 59. Europe Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2018-2023) Figure 60. Germany Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 61. France Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 62. UK Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 63. Italy Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 64. Russia Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 65. Middle East & Africa Network Point-of-Care Glucose Testing Device Sales Market Share by Country in 2022 Figure 66. Middle East & Africa Network Point-of-Care Glucose Testing Device Revenue Market Share by Country in 2022 Figure 67. Middle East & Africa Network Point-of-Care Glucose Testing Device Sales Market Share by Type (2018-2023) Figure 68. Middle East & Africa Network Point-of-Care Glucose Testing Device Sales Market Share by Application (2018-2023) Figure 69. Egypt Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 70. South Africa Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 71. Israel Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 72. Turkey Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 73. GCC Country Network Point-of-Care Glucose Testing Device Revenue Growth 2018-2023 ($ Millions) Figure 74. Manufacturing Cost Structure Analysis of Network Point-of-Care Glucose Testing Device in 2022 Figure 75. Manufacturing Process Analysis of Network Point-of-Care Glucose Testing Device Figure 76. Industry Chain Structure of Network Point-of-Care Glucose Testing Device Figure 77. Channels of Distribution Figure 78. Global Network Point-of-Care Glucose Testing Device Sales Market Forecast by Region (2024-2029) Figure 79. Global Network Point-of-Care Glucose Testing Device Revenue Market Share Forecast by Region (2024-2029) Figure 80. Global Network Point-of-Care Glucose Testing Device Sales Market Share Forecast by Type (2024-2029) Figure 81. Global Network Point-of-Care Glucose Testing Device Revenue Market Share Forecast by Type (2024-2029) Figure 82. Global Network Point-of-Care Glucose Testing Device Sales Market Share Forecast by Application (2024-2029) Figure 83. Global Network Point-of-Care Glucose Testing Device Revenue Market Share Forecast by Application (2024-2029)
